Annual FCF
-$123.00 M
-$73.46 M-148.29%
December 31, 2023
Summary
- As of February 23, 2025, TARS annual free cash flow is -$123.00 million, with the most recent change of -$73.46 million (-148.29%) on December 31, 2023.
- During the last 3 years, TARS annual FCF has fallen by -$101.40 million (-469.58%).
- TARS annual FCF is now -3989.78% below its all-time high of $3.16 million, reached on December 31, 2021.
Performance
TARS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$8.93 M
+$6.51 M+42.15%
September 30, 2024
Summary
- As of February 23, 2025, TARS quarterly free cash flow is -$8.93 million, with the most recent change of +$6.51 million (+42.15%) on September 30, 2024.
- Over the past year, TARS quarterly FCF has stayed the same.
- TARS quarterly FCF is now -143.51% below its all-time high of $20.54 million, reached on June 30, 2021.
Performance
TARS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$101.67 M
+$27.80 M+21.47%
September 30, 2024
Summary
- As of February 23, 2025, TARS TTM free cash flow is -$101.67 million, with the most recent change of +$27.80 million (+21.47%) on September 30, 2024.
- Over the past year, TARS TTM FCF has stayed the same.
- TARS TTM FCF is now -1917.57% below its all-time high of $5.59 million, reached on September 30, 2021.
Performance
TARS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
TARS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -148.3% | 0.0% | 0.0% |
| 3 y3 years | -469.6% | 0.0% | 0.0% |
| 5 y5 years | -10000.0% | 0.0% | 0.0% |
TARS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3989.8% | at low | -103.9% | +77.3% | -3315.5% | +26.7% |
| 5 y | 5-year | -3989.8% | at low | -143.5% | +77.3% | -1917.6% | +26.7% |
| alltime | all time | -3989.8% | at low | -143.5% | +77.3% | -1917.6% | +26.7% |
Tarsus Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.93 M(-42.1%) | -$101.67 M(-21.5%) |
| Jun 2024 | - | -$15.44 M(-59.3%) | -$129.48 M(-6.6%) |
| Mar 2024 | - | -$37.96 M(-3.5%) | -$138.65 M(+12.7%) |
| Dec 2023 | -$123.00 M(+148.3%) | -$39.34 M(+7.1%) | -$123.00 M(+29.9%) |
| Sep 2023 | - | -$36.74 M(+49.3%) | -$94.66 M(+23.5%) |
| Jun 2023 | - | -$24.61 M(+10.3%) | -$76.63 M(+35.9%) |
| Mar 2023 | - | -$22.31 M(+102.8%) | -$56.40 M(+13.9%) |
| Dec 2022 | -$49.54 M | -$11.00 M(-41.2%) | -$49.54 M(-2.7%) |
| Sep 2022 | - | -$18.71 M(+327.0%) | -$50.93 M(+101.8%) |
| Jun 2022 | - | -$4.38 M(-71.6%) | -$25.23 M(+7884.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$15.45 M(+24.6%) | -$316.00 K(-110.0%) |
| Dec 2021 | $3.16 M(-114.6%) | -$12.39 M(-277.3%) | $3.16 M(-43.5%) |
| Sep 2021 | - | $6.99 M(-66.0%) | $5.59 M(-169.0%) |
| Jun 2021 | - | $20.54 M(-271.6%) | -$8.10 M(-74.3%) |
| Mar 2021 | - | -$11.97 M(+20.1%) | -$31.53 M(+46.0%) |
| Dec 2020 | -$21.59 M(+461.2%) | -$9.96 M(+48.5%) | -$21.59 M(+85.7%) |
| Sep 2020 | - | -$6.71 M(+131.9%) | -$11.63 M(+136.2%) |
| Jun 2020 | - | -$2.89 M(+42.3%) | -$4.92 M(+142.3%) |
| Mar 2020 | - | -$2.03 M | -$2.03 M |
| Dec 2019 | -$3.85 M(+223.4%) | - | - |
| Dec 2018 | -$1.19 M | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual FCF year-on-year change?
- What is Tarsus Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly FCF year-on-year change?
- What is Tarsus Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM FCF year-on-year change?
What is Tarsus Pharmaceuticals annual free cash flow?
The current annual FCF of TARS is -$123.00 M
What is the all time high annual FCF for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual free cash flow is $3.16 M
What is Tarsus Pharmaceuticals annual FCF year-on-year change?
Over the past year, TARS annual free cash flow has changed by -$73.46 M (-148.29%)
What is Tarsus Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of TARS is -$8.93 M
What is the all time high quarterly FCF for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly free cash flow is $20.54 M
What is Tarsus Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, TARS quarterly free cash flow has changed by $0.00 (0.00%)
What is Tarsus Pharmaceuticals TTM free cash flow?
The current TTM FCF of TARS is -$101.67 M
What is the all time high TTM FCF for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM free cash flow is $5.59 M
What is Tarsus Pharmaceuticals TTM FCF year-on-year change?
Over the past year, TARS TTM free cash flow has changed by $0.00 (0.00%)